Dudediligence.

BioMarin Pharmaceutical Inc

BMRNNASDAQ · Pharmaceutical Preparations
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$4,318,227

5 notices · 69,711 sh

Oct 2025 to Oct 2026

Reported ·

$3,154,492

4 sales · 0 buys

Oct 2025 to Jun 2026

The two figures cover different periods.

None of the 4 reported sales carry the 10b5-1 box. Together they are 0.03% of the shares on issue.

PLANNED · FORM 144Oct 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2026-09-02: Davis George Eric, Form 1442026-05-07: Friberg Gregory R, Form 1442026-03-11: Guyer Charles Greg, Form 1442026-02-26: Friberg Gregory R, Form 1442026-02-26: Davis George Eric, Form 1442026-02-26: Davis George Eric, sold2026-02-26: Friberg Gregory R, sold2026-03-11: Guyer Charles Greg, sold2026-05-07: Friberg Gregory R, sold
under a no plan named▼ salesize is dollars

Form 144 notices, newest first

2026-09-02Davis George Eric, EVP, Chief Legal Officer$1,163,756
17,557 shno plan dateForm 4s on file end Jun 23144 ↗
2026-05-07Friberg Gregory R, EVP, Chief R&D Officer$176,682
3,281 shno plan date144 ↗
Form 4, 2026-05-11: sold 3,281 at $53.85 Form 4 ↗
2026-03-11Guyer Charles Greg, EVP, Chief Technical Officer$996,749
16,486 shno plan date144 ↗
Form 4, 2026-03-12: sold 16,486 at $60.46 Form 4 ↗
2026-02-26Friberg Gregory R, EVP, Chief R&D Officer$381,937
6,326 shno plan date144 ↗
Form 4, 2026-02-26: sold 6,326 at $60.38 Form 4 ↗
2026-02-26Davis George Eric, EVP, Chief Legal Officer$1,599,103
26,061 shno plan date144 ↗
Form 4, 2026-02-26: sold 26,061 at $61.36 Form 4 ↗